Evidence map›Paper›PMID 24759783›Full record

ArticleNature communications2014

Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4.

Joseph M Catanzaro, Namratha Sheshadri, Ji-An Pan, Yu Sun, Chanjuan Shi, Jinyu Li, R Scott Powers, Howard C Crawford, Wei-Xing Zong

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Bioactive Compounds and Signaling Pathways ofLife (Basel, Switzerland) · 2023
    Article
  17. ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses viaProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Joseph M Catanzaro *Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11794, USA.
Namratha Sheshadri *Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11794, USA.
Ji-An PanDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11794, USA.
Yu SunDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11794, USA.
Chanjuan ShiDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee 37232, USA.
Jinyu LiCancer Genome Center, Cold Spring Harbor Laboratory, Woodbury, New York 11797, USA.
R Scott PowersCancer Genome Center, Cold Spring Harbor Laboratory, Woodbury, New York 11797, USA.
Howard C CrawfordDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida 32224, USA.
Wei-Xing ZongDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11794, USA.
Stony Brook University · USMayo Clinic in Florida · US

Funding

Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETSU01CA168409 · NCI · COLD SPRING HARBOR LABORATORY · PI POWERS, SCOTT · 2012 to 2016
$7.3M
VIRAL ONCOLOGYT32CA009176 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HEARING, PATRICK · 1985 to 2012
$5.2M
Protein and redox homeostasis in cancer development and therapyR01CA129536 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI ZONG, WEI-XING · 2008 to 2022
$4.8M
ADAM17 in pancreatic cancer and pancreatitisR01CA159222 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRAWFORD, HOWARD C. · 2011 to 2015
$1.9M
Phosphatidylinositol 3-kinases and AutophagyR01GM097355 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI ZONG, WEI-XING · 2012 to 2015
$1.5M
MMP-7 IN Pacreatic Cancer and Chronic PancreatitisR01CA100126 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI CRAWFORD, HOWARD C. · 2004 to 2008
$1.2M
NCI NIH HHS P50 CA095103NCI NIH HHS P50CA095103NCI NIH HHS R01 CA100126NCI NIH HHS R01CA100126NCI NIH HHS R01 CA129536NCI NIH HHS R01CA129536NCI NIH HHS R01 CA159222NCI NIH HHS R01CA159222NCI NIH HHS T32 CA009176NCI NIH HHS T32CA009176NCI NIH HHS U01 CA168409NCI NIH HHS U01CA168409NIGMS NIH HHS R01 GM097355NIGMS NIH HHS R01GM97355
6 · The paper itself

Abstract

Mounting evidence indicates that oncogenic Ras can modulate cell autonomous inflammatory cytokine production, although the underlying mechanism remains unclear. Here we show that squamous cell carcinoma antigens 1 and 2 (SCCA1/2), members of the Serpin family of serine/cysteine protease inhibitors, are transcriptionally upregulated by oncogenic Ras via MAPK and the ETS family transcription factor PEA3. Increased SCCA expression leads to inhibition of protein turnover, unfolded protein response, activation of NF-κB and is essential for Ras-mediated cytokine production and tumour growth. Analysis of human colorectal and pancreatic tumour samples reveals a positive correlation between Ras mutation, enhanced SCCA expression and IL-6 expression. These results indicate that SCCA is a Ras-responsive factor that plays an important role in Ras-associated cytokine production and tumorigenesis.

Indexed as

Up-RegulationAntigens, NeoplasmCytokinesHumansInflammation MediatorsProto-Oncogene Proteins p21(ras)SerpinsAntigens, NeoplasmCytokinesInflammation MediatorsProto-Oncogene Proteins p21(ras)Serpinssquamous cell carcinoma-related antigen

Identifiers

PMID24759783
PMCPMC4025922
OpenAlexW1971514499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.